LANSOPRAZOLE | LANSOPRAZOLE DEXLANSOPRAZOLE | ATC A02BC03 ATC A02BD07 ATC A02BD03 ATC A02BD02 ATC A02BD10 ATC A02BD09 ATC A02BC53
METABOLISM ANTIULCERATIVE GASTRIC ACID PROTON-PUMP INHIBITORS | ORAL INTRAVENOUS | Cmax 4.6 MICROMOLAR Tmax 1.7 HOUR F 80 PERCENT VD 15.7 LITER PPB 97 PERCENT Cl 11.1 LITER / HOUR (65 KILOGRAM) HT 1.3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | (H+,K+) ATPASE | POTASSIUM-TRANSPORTING ATPASE INHIBITOR CHEMBL2095173 POTASSIUM-TRANSPORTING ATPASE P20648 POTASSIUM-TRANSPORTING ATPASE ALPHA CHAIN 1 HOMO SAPIENS ENZYME HYDROLASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |